Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Medical Dynamic MarketingJMDMF 77 Debt-to-Equity is 0.23 as of Mar. 2026, which is 15% above its 10-year median of 0.20. GuruFocus rates JMDMF with a GF Score™ of 77/100 and a GF Value™ of $3.47. The stock has 10 warning signs investors should review. Among 704 Medical Devices & Instruments companies, Japan Medical Dynamic Marketing ranks worse than 53.84% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Japan Medical Dynamic Marketing's Debt-to-Equity or its related term are showing as below:
JMDMF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.2 Max: 0.51
Current: 0.27
During the past 13 years, the highest Debt-to-Equity Ratio of Japan Medical Dynamic Marketing was 0.51. The lowest was 0.06. And the median was 0.20.
JMDMF's Debt-to-Equity is ranked worse than 53.84% of 704
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs JMDMF: 0.27
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Japan Medical Dynamic Marketing Debt-to-Equity Related Terms
Japan Medical Dynamic Marketing Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Medical Dynamic Marketing Debt-to-Equity Chart
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Medical Dynamic Marketing (JMDMF) has a Debt-to-Equity of 0.23 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Japan Medical Dynamic Marketing and its competitors. This is 15% above median its historical median of 0.20. Over the past decade, Japan Medical Dynamic Marketing's Debt-to-Equity has ranged from 0.06 to 0.51. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #379 out of 704 companies in the Medical Devices & Instruments industry, placing it in the top 53.8%.
Is Japan Medical Dynamic Marketing's Debt-to-Equity too high?
Japan Medical Dynamic Marketing's current Debt-to-Equity of 0.23 is 15% above median its 10-year median of 0.20. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.51. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Japan Medical Dynamic Marketing's value of 0.23 is 0% at this industry median. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #379 out of 704 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #379 out of 704 companies for Debt-to-Equity. This places Japan Medical Dynamic Marketing in the lower half of its industry. The industry median Debt-to-Equity is 0.23. Japan Medical Dynamic Marketing's value of 0.23 is 0% at this benchmark. Historically, Japan Medical Dynamic Marketing's own Debt-to-Equity has ranged from 0.06 to 0.51 over the past decade. While the company's 10-year median is 0.20 vs. the industry median of 0.23, Japan Medical Dynamic Marketing has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Medical Dynamic Marketing's current Debt-to-Equity of 0.23 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current Debt-to-Equity is 0.23, which is 15% above median its own 10-year median of 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (JMDMF) has a current Debt-to-Equity of 0.23. The stock's GF Value™ is $3.47, compared to a current price of $5.00 — trading 44.1% above its estimated fair value. The current Debt-to-Equity is 0.23, which is 15% above median its 10-year median of 0.20 and 0% at the Medical Devices & Instruments industry median of 0.23. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (JMDMF), the current Debt-to-Equity is 0.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (JMDMF) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of $5.00 is trading 44.1% above its estimated GF Value™ of $3.47.
Key valuation signals for JMDMF:
Debt-to-Equity: 0.23 (15% above median its 10-year median of 0.20)
GF Value™: $3.47 vs. price of $5.00 (44.1% above fair value)
Industry Position: 0% at the Medical Devices & Instruments median (#379 of 704)
No single metric tells the full story. See the JMDMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score
Get the complete analysis for JMDMF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMDMF has been successfully added to your 
